NN Investment Partners Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
NN Investment Partners Holdings's GILD Position: Q1 2022 in Review
NN Investment Partners Holdings reduced its Gilead Sciences (GILD) stake by 0.11% in Q1 2022, selling an estimated $16.9K and leaving 244,421 shares worth $14.5M. The position accounts for 0.08% of the portfolio, ranked #217.
NN Investment Partners Holdings first reported a position in GILD in Q1 2016 and has held it in 25 quarters since. The position peaked at $180M in Q1 2016. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- NN Investment Partners Holdings held 244,421 shares of Gilead Sciences worth $14.5M as of Q1 2022.
- NN Investment Partners Holdings sold 265 Gilead Sciences shares in Q1 2022, an estimated $16.9K.
- Gilead Sciences made up 0.08% of NN Investment Partners Holdings's portfolio in Q1 2022, its #217 holding.
- NN Investment Partners Holdings first reported a position in Gilead Sciences in Q1 2016 and has held it in 25 quarters since.
- NN Investment Partners Holdings's Gilead Sciences position peaked at $180M in Q1 2016.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.